相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A low-passage insect-cell isolate of bluetongue virus uses a macropinocytosis-like entry pathway to infect natural target cells derived from the bovine host
Lisa M. Stevens et al.
JOURNAL OF GENERAL VIROLOGY (2019)
Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine
Susan J. Dennis et al.
PLANT BIOTECHNOLOGY JOURNAL (2018)
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
Eva Calvo-Pinilla et al.
ANTIVIRAL RESEARCH (2018)
African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform
Piet A. van Rijn et al.
VACCINE (2018)
Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
Susan J. Dennis et al.
VETERINARY RESEARCH (2018)
Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines
Cristina C. Celma et al.
JOURNAL OF VIROLOGY (2017)
B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
Evans M. Mathebula et al.
ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH (2017)
Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine
C. T. Weyer et al.
VACCINE (2017)
Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination
Nicola Mary Manning et al.
VACCINE (2017)
Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge
Valeria Lulla et al.
VACCINE (2017)
Bluetongue virus structure and assembly
Polly Roy
CURRENT OPINION IN VIROLOGY (2017)
Atomic model of a nonenveloped virus reveals pH sensors for a coordinated process of cell entry
Xing Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Atomic model of a nonenveloped virus reveals pH sensors for a coordinated process of cell entry
Xing Zhang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Cellular Casein Kinase 2 and Protein Phosphatase 2A Modulate Replication Site Assembly of Bluetongue Virus
Bjorn-Patrick Mohl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes
Valeria Lulla et al.
JOURNAL OF VIROLOGY (2016)
Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment
George P. Lomonossoff et al.
SCIENCE (2016)
Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus
Andele M. Conradie et al.
VIROLOGY (2016)
Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
Piet A. van Rijn et al.
VIROLOGY JOURNAL (2016)
Synthesis of empty african horse sickness virus particles
Sonja Maree et al.
VIRUS RESEARCH (2016)
African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014
Camilla T. Weyer et al.
EMERGING INFECTIOUS DISEASES (2016)
Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
Eva Calvo-Pinilla et al.
ANTIVIRAL RESEARCH (2015)
Development of three triplex real-time reverse transcription PCR assays for the qualitative molecular typing of the nine serotypes of African horse sickness virus
Camilla T. Weyer et al.
JOURNAL OF VIROLOGICAL METHODS (2015)
VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
Sandra G. P. van de Water et al.
JOURNAL OF VIROLOGY (2015)
Directed genetic modification of African horse sickness virus by reverse genetics
Elaine Vermaak et al.
SOUTH AFRICAN JOURNAL OF SCIENCE (2015)
Application of Bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2
Femke Feenstra et al.
VACCINE (2015)
Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-/-) mice.
Francisco de la Poza et al.
VIRUS RESEARCH (2015)
Characterising Non-Structural Protein NS4 of African Horse Sickness Virus
Lizahn Zwart et al.
PLOS ONE (2015)
Bioengineering Virus-Like Particles as Vaccines
Linda H. L. Lua et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
Comparative ultrastructural characterization of African horse sickness virus-infected mammalian and insect cells reveals a novel potential virus release mechanism from insect cells
E. Venter et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
Katarzyna Bachanek-Bankowska et al.
PLOS ONE (2014)
Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
Yuta Kanai et al.
VACCINE (2014)
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
Berta Alberca et al.
VACCINE (2014)
Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation
Eva Calvo-Pinilla et al.
VIRUS RESEARCH (2014)
The molecular biology of Bluetongue virus replication
Avnish Patel et al.
VIRUS RESEARCH (2014)
Commercial Aspects of Pharmaceutical Protein Production in Plants
Rainer Fischer et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
African horse sickness in naturally infected, immunised horses
C. T. Weyer et al.
EQUINE VETERINARY JOURNAL (2013)
Recovery Of African horse sickness virus from synthetic RNA
Yuuki Kaname et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Diagnostic accuracy of a duplex real-time reverse transcription quantitative PCR assay for detection of African horse sickness virus
Alan J. Guthrie et al.
JOURNAL OF VIROLOGICAL METHODS (2013)
A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles
Eva C. Thuenemann et al.
PLANT BIOTECHNOLOGY JOURNAL (2013)
Recombinant MVA vaccines: dispelling the myths
Matthew G. Cottingham et al.
VACCINE (2013)
Clinical development of Modified Vaccinia virus Ankara vaccines
Sarah C. Gilbert
VACCINE (2013)
Focus on: African horse sickness
Richard Hopley et al.
VETERINARY RECORD (2013)
Structural Insight into African Horsesickness Virus Infection
Violeta Manole et al.
JOURNAL OF VIROLOGY (2012)
Risk of introducing African horse sickness virus into the Netherlands by international equine movements
C. J. de Vos et al.
PREVENTIVE VETERINARY MEDICINE (2012)
Virus-specific CD8+ T-cells detected in PBMC from horses vaccinated against African horse sickness virus
Alri Pretorius et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses
H. El Garch et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis
Mark Boyce et al.
VIROLOGY JOURNAL (2012)
Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus
Cristina C. P. Celma et al.
JOURNAL OF VIROLOGY (2011)
Identification and Characterization of a Novel Non-Structural Protein of Bluetongue Virus
Maxime Ratinier et al.
PLOS PATHOGENS (2011)
A reverse genetics system of African horse sickness virus reveals existence of primary replication
Eiko Matsuo et al.
FEBS LETTERS (2010)
Measurement of bluetongue virus binding to a mammalian cell surface receptor by an in situ immune fluorescent staining technique
James O. Mecham et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Development and optimisation of a duplex real-time reverse transcription quantitative PCR assay targeting the VP7 and NS2 genes of African horse sickness virus
M. Quan et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Plant-made vaccines for humans and animals
Edward P. Rybicki
PLANT BIOTECHNOLOGY JOURNAL (2010)
Bluetongue virus coat protein VP2 contains sialic acid-binding domains, and VP5 resembles enveloped virus fusion proteins
Xing Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus
M. Stewart et al.
VACCINE (2010)
In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6
Beate F. von Teichman et al.
VACCINE (2010)
A Viral Nonstructural Protein Regulates Bluetongue Virus Trafficking and Release
Cristina C. P. Celma et al.
JOURNAL OF VIROLOGY (2009)
Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
Rachael Chiam et al.
PLOS ONE (2009)
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
Alan J. Guthrie et al.
VACCINE (2009)
Equine travellers to the Olympic Games in Hong Kong 2008: A review of worldwide challenges to equine health, with particular reference to vector-borne diseases
C. Herholz et al.
EQUINE VETERINARY JOURNAL (2008)
Molecular epidemiology of the African horse sickness virus S10 gene
Melvyn Quan et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Real-time fluorogenic reverse transcription polymerase chain reaction assay for detection of African horse sickness virus
Montserrat Aguero et al.
JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION (2008)
Novel gel-based and real-time PCR assays for the improved detection of African horse sickness virus
Belen Rodriguez-Sanchez et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Serotype-specific detection of African horsesickness virus by real-time PCR and the influence of genetic variations
J. J. O. Koekemoer
JOURNAL OF VIROLOGICAL METHODS (2008)
Development of reverse genetics systems for bluetongue virus: Recovery of infectious virus from synthetic RNA transcripts
Mark Boyce et al.
JOURNAL OF VIROLOGY (2008)
Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals
Beate F. von Teichman et al.
VACCINE (2008)
Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness
N. James MacLachlan et al.
VACCINE (2007)
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly
Alak Kanti Kar et al.
BMC MOLECULAR BIOLOGY (2007)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Towards the preparative and large-scale precision manufacture of virus-like particles
LK Pattenden et al.
TRENDS IN BIOTECHNOLOGY (2005)
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies
J Modrof et al.
JOURNAL OF VIROLOGY (2005)
Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera
S Maree et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity
M Boyce et al.
JOURNAL OF VIROLOGY (2004)
A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity
M Forzan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Interactions between the inner and outer capsids of bluetongue virus
EL Nason et al.
JOURNAL OF VIROLOGY (2004)
The production of recombinant pharmaceutical proteins in plants
JKC Ma et al.
NATURE REVIEWS GENETICS (2003)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release
AR Beaton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Virus-like particles as a modular system for novel vaccines
F Lechner et al.
INTERVIROLOGY (2002)
The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant
M Scanlen et al.
VACCINE (2002)
Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides
JL Martínez-Torrecuadrada et al.
JOURNAL OF GENERAL VIROLOGY (2001)
Expression and functional characterization of bluetongue virus VP5 protein: Role in cellular permeabilization
SH Hassan et al.
JOURNAL OF VIROLOGY (2001)
Cloning, sequencing and expression of the gene that encodes the major neutralisation-specific antigen of African horsesickness virus serotype 9
M Venter et al.
JOURNAL OF VIROLOGICAL METHODS (2000)
Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries
L Bentley et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Identification and differentiation of the nine African horse sickness virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2
C Sailleau et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Functional dissection of the major structural protein of bluetongue virus: Identification of key residues within VP7 essential for capsid assembly
CK Limn et al.
JOURNAL OF VIROLOGY (2000)
分享论文
